Does FAM-TRASTUZUMAB DERUXTECAN-NXKI Cause Decreased appetite? 301 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 301 reports of Decreased appetite have been filed in association with FAM-TRASTUZUMAB DERUXTECAN-NXKI. This represents 4.0% of all adverse event reports for FAM-TRASTUZUMAB DERUXTECAN-NXKI.
301
Reports of Decreased appetite with FAM-TRASTUZUMAB DERUXTECAN-NXKI
4.0%
of all FAM-TRASTUZUMAB DERUXTECAN-NXKI reports
71
Deaths
133
Hospitalizations
How Dangerous Is Decreased appetite From FAM-TRASTUZUMAB DERUXTECAN-NXKI?
Of the 301 reports, 71 (23.6%) resulted in death, 133 (44.2%) required hospitalization, and 3 (1.0%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FAM-TRASTUZUMAB DERUXTECAN-NXKI. However, 301 reports have been filed with the FAERS database.
What Other Side Effects Does FAM-TRASTUZUMAB DERUXTECAN-NXKI Cause?
Nausea (1,037)
Interstitial lung disease (880)
Disease progression (794)
Death (717)
Fatigue (652)
Off label use (651)
Vomiting (464)
Diarrhoea (463)
Pneumonitis (337)
No adverse event (315)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which FAM-TRASTUZUMAB DERUXTECAN-NXKI Alternatives Have Lower Decreased appetite Risk?
FAM-TRASTUZUMAB DERUXTECAN-NXKI vs FAMCICLOVIR
FAM-TRASTUZUMAB DERUXTECAN-NXKI vs FAMOTIDINE
FAM-TRASTUZUMAB DERUXTECAN-NXKI vs FAMOTIDINE\IBUPROFEN
FAM-TRASTUZUMAB DERUXTECAN-NXKI vs FARICIMAB
FAM-TRASTUZUMAB DERUXTECAN-NXKI vs FARICIMAB-SVOA